Microencapsulated chelating agents and their use in removing metal ions from aqueous solutions

Claim 2

A process for the purification of an aqueous solution containing metal ion impurities which comprises contacting said solution with a plurality of microcapsules, each comprising a liquid core material, which is substantially insoluble in water, consisting essentially of a metal ion chelating agent selected from the group consisting of -diketones, 8-hydroxyquinolines, and oximes, enclosed within a solid permeable shell of a material selected from the group consisting of polyurea and ureaformaldehyde resins, wherein said metal ion impurities pass through said shell of said microcapsules and are chelated by said chelating agents, and subsequently separating said microcapsules from said solution.

Claim 3

The method in accordance with claim 1 in which said chelating agent is dissolved in an inert organic solvent which is substantially insoluble in water.

Claim 4

The method in accordance with claim 1 in which said chelating agent is dissolved in an inert organic solvent which is substantially insoluble in water, and said chelating agent is selected from the group consisting of (a) β-diketones having the formula ##STR6## in which R 1 is selected from the group consisting of C 3 -C 12 alkyl, phenyl, furyl and thiofuryl; R 2 is selected from the group consisting of C 1 -C 12 alkyl, trifluoromethyl, phenyl, furyl, and thiofuryl; and X is oxygen or sulfur; (b) 8-hydroxyquinolines or their thiol analogs having the formula ##STR7## in which R 3 , R 4 and R 5 are independently selected from the group consisting of hydrogen, halogen, C 1 -C 3 alkyl, nitro, nitroso, sulfo and sulfo-trialkylammonium salts, and X is oxygen or sulfur; (c) oximes having the formula ##STR8## in which R 6 is selected from the group consisting of hydrogen, C 1 -C 3 alkyl, and phenyl; and R 6 i selected from the group consisting of C 1 -C 3 hydroxyalkyl, β-hydroxybenzyl and hydroxyphenyl; and (d) dioximes of the formula ##STR9## in which R 8 is selected from the group consisting of C 1 -C 3 alkyl, phenyl and furyl.

Claim 5

The method according to claim 1 in which said chelating agent is dissolved in an inert organic solvent which is substantially insoluble in water, and said chelating agent is selected from the group consisting of 8-hydroxyquinoline, salicylaldoxime, and β-diketones having the formula ##STR10## in which R 1 is selected from the group consisting of C 3 -C 12 alkyl, phenyl, furyl and thiofuryl; R 2 is selected from the group consisting of C 1 -C 12 alkyl, trifluoromethyl, phenyl, furyl, and thiofuryl; and X is oxygen or sulfur.

Claim 6

The method in accordance with claim 1 in which said chelating agent is 8-hydroxyquinoline disolved in an inert organic solvent which is substantially insoluble in water, and said shell material is a polyurea resin.

Claim 7

The method in accordance with claim 1 in which said chelating agent is 8-hydroxyquinoline dissolved in an inert organic solvent which is substantially insoluble in water, and said shell material is a polyurea resin formed from an aromatic polyisocyante.

Claim 8

The method in accordance with claim 1 in which said chelating agent is 8-hydroxyquinoline disolved in an inert organic solvent which is substantially insoluble in water, and said shell material is a polyurea resin formed from a mixture of a polymethylene polyphenylisocyanate and toluene diisocyanate.

Claim 9

The method in accordance with claim 1 in which said chelating agent is salicylaldoxime dissolved in an inert organic solvent which is substantially insoluble in water, and said shell material is a urea-formaldehyde resin.

Claim 10

The method in accordance with claim 1 in which said chelating agent is salicyaldoxime dissolved in an inert organic solvent which is substantially insoluble in water, and said shell material is a urea-formaldehyde resin formed from a urea-formaldehyde prepolymer having from about 50% to about 98% of the hydroxyl hydrogen atoms replaced by C 4 -C 6 alkyl groups.

Claim 11

The method in accordance with claim 1 in which said chelating agent is salicylaldoxime dissolved in an inert organic solvent which is substantially insoluble in water, and said shell material is a urea-formaldehyde resin formed from a urea-formaldehyde prepolymer having from about 70% to about 90% of the hydroxyl hydrogen atoms replaced by C 4 -C 6 alkyl groups.

Claim 12

The method in accordance with claim 1 in which said chelating agent is salicylaldoxime dissolved in an inert organic solvent which is substantially insoluble in water, and said shell material is a urea-formaldehyde resin formed from a urea-formaldehyde prepolymer having from about 70% to about 90% of the hydroxyl hydrogen atoms replaced by a n-butyl group.

Claim 13

The method in accordance with claim 1 in which said chelating agent is a β-diketone having the formula ##STR11## in which R 1 is selected from the group consisting of C 3 -C 12 alkyl, phenyl furyl and thiofuryl; R 2 is selected from the group consisting of C 1 -C 12 alkyl, trifluoromethyl, phenyl, furyl, and thiofuryl; and X is oxygen or sulfur; dissolved in an inert organic solvent which is substantially insoluble inwater, and said shell material is a polyurea resin.

Claim 14

The method in accordance with claim 1 in which said chelating agent is a β-diketone having the formula ##STR12## in which R 1 is selected from the group consisting of C 3 -C 12 alkyl, phenyl furyl and thiofuryl; R 2 is selected from the group consisting of C 1 -C 12 alkyl, trifluoromethyl, phenyl, furyl, and thiofuryl; and X is oxygen or sulfur; dissolved in an inert organic solvent which is substantially insoluble in water, and said shell material is a polyrea resin formed from an aromatic polyisocyanate.